glp-1 while breastfeeding Are Safe Breastfeeding? Understanding the Facts – PlexusDx Ep. 84 - GLP-1 Medications

The community-derived planning ranges should not be read as clinically validated doses

The case presentations are retrospective and observational, designed to explore potential patterns without inferring causation between variables

Interested in learning more about GLP-1 medications

Signs you may need to decrease dose: persistent injection site reactions, nausea, fatigue, or excessive skin sensitivity

not approved Tirzepatide (Zepbound) Approved (Zepbound, Mounjaro) Semaglutide alone (Wegovy) Approved (Wegovy, Ozempic) Cagrilintide alone Investigational Feature Head-to-head data CagriSema Did not meet non-inferiority vs tirzepatide at 84 wks (Reuters Feb 2026) Tirzepatide (Zepbound) Semaglutide alone (Wegovy) Cagrilintide alone These compounds are not interchangeable